Compare BLSH & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLSH | NOVT |
|---|---|---|
| Founded | 2020 | 1968 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.9B |
| IPO Year | N/A | 1999 |
| Metric | BLSH | NOVT |
|---|---|---|
| Price | $34.44 | $112.87 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 1 |
| Target Price | $51.91 | ★ $133.00 |
| AVG Volume (30 Days) | ★ 1.2M | 369.3K |
| Earning Date | 02-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.47 |
| Revenue | N/A | ★ $521,290,000.00 |
| Revenue This Year | $64.28 | $8.71 |
| Revenue Next Year | $17.88 | $6.47 |
| P/E Ratio | ★ N/A | $80.67 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $24.69 | $98.27 |
| 52 Week High | $74.98 | $149.95 |
| Indicator | BLSH | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 35.72 |
| Support Level | $34.24 | $111.58 |
| Resistance Level | $40.58 | $125.37 |
| Average True Range (ATR) | 2.00 | 5.48 |
| MACD | -0.35 | -0.40 |
| Stochastic Oscillator | 5.13 | 7.64 |
Bullish is an institutionally focused global digital asset platform focused on providing market infrastructure and information services. Its objective is to provide mission critical products and services that are designed to help institutions grow their businesses, empower individual investors, and drive the adoption of stablecoins, digital assets, and blockchain technology. It expanded its product offering to provide trusted insights, authoritative news, data, indices and transparent analysis to the digital assets industry while facilitating partnerships, investment opportunities, and community engagement through its flagship Consensus conference.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.